A four-week randomised controlled induction trial, CLASSIC I (Clinical Assessment of Adalimumab Safety and Efficacy Studied as Induction Therapy in Crohn’s Disease) demonstrated clinical efficacy at ...

Health New England announced Monday that it will shift coverage of the biologic drug Humira to more affordable FDA-approved biosimilars starting next month for members of its commercial health plans.

ABBV eyes $24.7 billion from Skyrizi and Rinvoq in 2025 as ex-Humira growth offsets sharp sales drop post-U.S. patent loss.

Humira’s strengths are listed in the following charts in milligrams (mg) of active drug per milliliter (mL) of solution. Humira comes in several forms, all of which are used to give the drug as ...

Hero MotoCorp's premium maxi-scooter, the Xoom 160 was launched in the Indian market in January 2025. However, the deliveries of the scooters are yet to begin.

The Air Quality Index was around 160 in many parts of the upper Midwest, indicating poor conditions. The Air Quality Index , or AQI, measures how clean or polluted the air is, indicating which health ...

APLD stock is now up 160% over the past month, and this is mostly due to the company signing a deal with CoreWeave (NASDAQ: CRWV) for $7 billion. CRWV is also up over 10% so far today.

Samsung Bioepis and Organon shared that the Food and Drug Administration has designated the Hadlima (adalimumab-bwwd) high- and low-concentration (40 mg/0.4 ml, 40 mg/0.8 ml) autoinjectors and ...

The Food and Drug Administration (FDA) has designated Hadlima™ (adalimumab-bwwd) an interchangeable biosimilar to Humira ® (adalimumab).. Hadlima, a tumor necrosis factor (TNF) blocker, is indicated ...